Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: J Immunol. 2018 May 11;200(12):3942–3949. doi: 10.4049/jimmunol.1800259

Figure 6.

Figure 6

Theoretical model for the modulatory role of Slit2 on intra-orbital pathogenesis of TAO. When CD34 OF-derived Slit2 predominates, the inflammatory phenotype of CD34+ OF is down regulated and the patient with GD either fails to manifest TAO or the disease is mild (Left panel). When CD34+ OF dominates the fibroblast population and the impact of Slit2 is inadequate, TAO is severe (Right panel).